Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Praxis Biologics vaccine grants

Executive Summary

Two $50,000 Phase I Small Business Innovation Research grants received by firm. The first, from the Natl. Institute of Allergies & Infectious Diseases, covers development of a new infant Haemophilus influenzae bacterial (HIB) vaccine. Praxis already markets a Hib conjugate vaccine, B-CAPSA-I, and has completed Phase II study for a successor compound. The second grant, from the U.S. Department of Agriculture, is for research on a vaccine for Salmonella and other infections in poultry.

You may also be interested in...



Government Report Outlines Costs, Savings Of Major Regs

The HHS was responsible for the most major regulations over the last few years of any agency, an OMB report shows.

J.P. Morgan Extras: Pandemic Impact on Launch, Production, Development And More

Additional views from the virtual J.P. Morgan Healthcare Conference on ways the COVID-19 pandemic has affected business practices and lessons learned for the future.

New Filings At The EMA

New medicines under evaluation at the European Medicines Agency.

UsernamePublicRestriction

Register

LL033172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel